Health, Water, Energy

The European Investment Bank (EIB) and the Government of Canada have taken an important step toward strengthening cooperation on critical raw materials. At the PDAC 2026 conference in Toronto, the two sides signed a non‑binding Letter of Intent, signalling their commitment to closer cooperation on securing reliable and sustainable supply chains for the minerals and metals that power the green and digital transitions, innovation as well as security and defense.

The European Investment Bank (EIB) is providing €40 million in venture debt financing to Meva Energy AB (“Meva”), a Swedish cleantech company pioneering modular gasification plants that convert biomass residues into climate-neutral, industrial-grade biogas. This innovative fuel can directly replace fossil gas in a range of industries, supporting Europe’s transition to cleaner energy and greater energy independence.

The European Investment Bank (EIB) and the European Commission (EC) are teaming up with BioNTech to help advance a messenger RNA (mRNA) vaccine manufacturing facility in Kigali, Rwanda. To support this project, BioNTech has been awarded a blended financing option of up to €95 million: a €35 million Commission grant, and the possibility to take out a loan of up to €60 million from the EIB. The facility is designed to produce mRNA vaccines for diseases that matter most to Africa – such as malaria, tuberculosis, HIV, and mpox – if successfully developed and approved.